[HTML][HTML] Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System
T Komori - Laboratory Investigation, 2022 - Elsevier
The grading of gliomas based on histological features has been a subject of debate for
several decades. A consensus has not yet been reached because of technical limitations …
several decades. A consensus has not yet been reached because of technical limitations …
Emerging applications of artificial intelligence in neuro-oncology
Due to the exponential growth of computational algorithms, artificial intelligence (AI)
methods are poised to improve the precision of diagnostic and therapeutic methods in …
methods are poised to improve the precision of diagnostic and therapeutic methods in …
Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas
P Chang, J Grinband, BD Weinberg… - American Journal …, 2018 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The World Health Organization has recently placed new
emphasis on the integration of genetic information for gliomas. While tissue sampling …
emphasis on the integration of genetic information for gliomas. While tissue sampling …
T2–FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project
Purpose: Lower-grade gliomas (WHO grade II/III) have been classified into clinically relevant
molecular subtypes based on IDH and 1p/19q mutation status. The purpose was to …
molecular subtypes based on IDH and 1p/19q mutation status. The purpose was to …
2016 updates to the WHO brain tumor classification system: what the radiologist needs to know
DR Johnson, JB Guerin, C Giannini, JM Morris… - Radiographics, 2017 - pubs.rsna.org
Radiologists play a key role in brain tumor diagnosis and management and must stay
abreast of developments in the field to advance patient care and communicate with other …
abreast of developments in the field to advance patient care and communicate with other …
World Health Organization grade II/III glioma molecular status: prediction by MRI morphologic features and apparent diffusion coefficient
J Maynard, S Okuchi, S Wastling, AA Busaidi… - Radiology, 2020 - pubs.rsna.org
Background A readily implemented MRI biomarker for glioma genotyping is currently
lacking. Purpose To evaluate clinically available MRI parameters for predicting isocitrate …
lacking. Purpose To evaluate clinically available MRI parameters for predicting isocitrate …
Noninvasive determination of IDH and 1p19q status of lower-grade gliomas using MRI radiomics: a systematic review
AP Bhandari, R Liong, J Koppen… - American Journal …, 2021 - Am Soc Neuroradiology
BACKGROUND: Determination of isocitrate dehydrogenase (IDH) status and, if IDH-mutant,
assessing 1p19q codeletion are an important component of diagnosis of World Health …
assessing 1p19q codeletion are an important component of diagnosis of World Health …
“Real world” use of a highly reliable imaging sign:“T2-FLAIR mismatch” for identification of IDH mutant astrocytomas
R Jain, DR Johnson, SH Patel, M Castillo… - Neuro …, 2020 - academic.oup.com
AbstractThe T2-FLAIR (fluid attenuated inversion recovery) mismatch sign is an easily
detectable imaging sign on routine clinical MRI studies that suggests diagnosis of isocitrate …
detectable imaging sign on routine clinical MRI studies that suggests diagnosis of isocitrate …
Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review
A Lasocki, M Anjari, S Ӧrs Kokurcan, SC Thust - Neuroradiology, 2021 - Springer
Purpose Molecular parameters have become integral to glioma diagnosis. Much of
radiogenomics research has focused on the use of advanced MRI techniques, but …
radiogenomics research has focused on the use of advanced MRI techniques, but …
MRI features can predict 1p/19q status in intracranial gliomas
A Lasocki, F Gaillard, A Gorelik… - American Journal of …, 2018 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The 2016 revision of the World Health Organization
Classification of Tumors of the Central Nervous System mandates codeletion of …
Classification of Tumors of the Central Nervous System mandates codeletion of …